Sangamo Therapeutics Inc. (SGMO)

0.57

-0.09 (-13.08%)

At close: Apr 01, 2025, 3:59 PM

0.57

0.85%

After-hours: Apr 01, 2025, 07:46 PM EDT

Sangamo Therapeutics Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-97.94M	-257.83M	-192.28M	-178.3M	-121.12M
Depreciation & Amortization	9.36M	22.19M	20.56M	17.64M	13.37M
Stock-Based Compensation	12.38M	27.36M	31.65M	32.96M	25.71M
Other Working Capital	3.55M	-172.77M	-98M	-101.11M	220.9M
Other Non-Cash Items	4.55M	153.8M	-1.24M	-6.43M	-666K
Deferred Income Tax	n/a	-6.33M	n/a	2.77M	n/a
Change in Working Capital	4.51M	-164.03M	-82.32M	-101.89M	252.59M
Operating Cash Flow	-67.14M	-224.84M	-223.63M	-233.25M	169.88M
Capital Expenditures	-267K	-21.16M	-20.17M	-23.28M	-14.71M
Acquisitions	n/a	n/a	-79.46M	-119K	-704K
Purchase of Investments	n/a	-59.55M	-277.39M	-338.16M	-570.78M
Sales Maturities Of Investments	35.84M	234.24M	356.85M	609.75M	314.57M
Other Investing Acitivies	1.95M	n/a	79.46M	-119K	-704K
Investing Cash Flow	37.52M	153.53M	59.28M	248.2M	-271.63M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	290K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-614K	-518K	-209K	5.76M	10.57M
Financial Cash Flow	28.38M	14.59M	84.66M	32.86M	153.1M
Net Cash Flow	-3.29M	-55.24M	-78.43M	47.54M	50.9M
Free Cash Flow	-67.41M	-246M	-243.8M	-256.53M	155.16M